Fluence Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.22 Cr
- Revenue Growth 79.92%
- Profit Growth 119.31%
- Ebitda 111.60%
- Net Worth 77.78%
- Total Assets 52.76%
About Fluence Pharma
Fluence Pharma Private Limited (FPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 March 2012 and has a history of 12 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.22 Cr.
Rajendrasingh Rajput, Ashokkumar Bhusari, and Abhijit Paul serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233MH2012PTC227677
- Company No.
227677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Fluence Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendrasingh Rajput  | Director | 18-Feb-2022 | Current |
| Ashokkumar Bhusari | Director | 05-Mar-2012 | Current |
| Abhijit Paul | Director | 18-Feb-2022 | Current |
Financial Performance of Fluence Pharma.
Fluence Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.92% increase. The company also saw a substantial improvement in profitability, with a 119.31% increase in profit. The company's net worth Soared by an impressive increase of 77.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fluence Pharma?
Unlock access to Fluence Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Era Pharmaceuticals Private LimitedAshokkumar Bhusari is a mutual person
Dr Paul's Multispeciality Clinic Private LimitedAbhijit Paul is a mutual person
Dr Paul's Cosmeceuticals Private LimitedAbhijit Paul is a mutual person
Dr. Rajesh Rajput Hair Restore LlpRajendrasingh Rajput is a mutual person
- Nuri Sciences Private Limited
Rajendrasingh Rajput is a mutual person
- Era Life Sciences Llp
Ashokkumar Bhusari is a mutual person
Charges (Loans)
₹52.20 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 5.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2023 | Axis Bank Limited | ₹3.75 Cr | Open |
| 18 Mar 2021 | Axis Bank Limited | ₹4.00 M | Open |
| 29 Oct 2015 | Axis Bank Limited | ₹1.07 Cr | Open |
How Many Employees Work at Fluence Pharma?
Unlock and access historical data on people associated with Fluence Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fluence Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fluence Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
